Longevity Health Holdings Inc. Delisted from Nasdaq, Moves to OTC Markets Following Rule Violation
Longevity Health Holdings Inc., a Delaware-based corporation, announced that it received a notice from the Nasdaq Stock Market LLC on September 10, 2025, regarding a failure to meet Nasdaq Listing Rule 5550(b)(2). Consequently, the Nasdaq Panel has decided to delist the company's securities from the Nasdaq Capital Market, effective at the start of trading on September 12, 2025. Following this decision, the company's common stock and warrants will be traded on the over-the-counter markets operated by OTC Markets Group, Inc. Despite this transition, Longevity Health Holdings intends to maintain its operations and continue filing reports as required by the Securities Exchange Act of 1934. The company also remains committed to pursuing a merger with True Health Inc. and relisting the merged entity's securities on Nasdaq.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longevity Health Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-114421), on September 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.